Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Archives of Dermatology|January 1, 1978
Progressive cribriform and zosteriform hyperpigmentationJ M Rower, R D Carr, E D LowneyArchives of Dermatology|December 1, 1982
Increased helper-suppressor T-cell ratio in psoriasisD J Ligresti, J C Neff, E D LowneyArchives of Dermatology|August 1, 1979
Folded skin associated with underlying nevus lipomatosusE W Gardner, H M Miller, E D LowneyDiabetic Medicine : a Journal of the British Diabetic Association|January 17, 2016
Drug development from the bench to the pharmacy: with special reference to dipeptidyl peptidase-4 inhibitor developmentR D CarrArchives of Physical Medicine and Rehabilitation|January 1, 1987
Ground reaction forces during ambulation in parkinsonism: pilot studyS H Koozekanani, M T Balmaseda, M T Fatehi, et al.Diabetic Medicine : a Journal of the British Diabetic Association|May 20, 2020
Inhibitors of dipeptidyl peptidase-4 as therapeutic agents for individuals with type 2 diabetes: a 25-year journeyR D Carr, A SolomonDecubitus|August 1, 1990
Clinical evaluation of a polymeric membrane dressing in the treatment of pressure ulcersR D Carr, D E LalagosDrugs of Today (Barcelona, Spain : 1998)|September 16, 2003
Glucagon-like peptide-1: a basis for new approaches to the management of diabetesC F Deacon, J J Holst, R D CarrJournal of Gambling Studies|November 16, 2013
Video lottery gambling: Effects on pathological gamblers seeking treatment in South DakotaT Morgan, L Kofoed, J Buchkoski, et al.Diabetologia|July 19, 2005
Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pigA Plamboeck, J J Holst, R D Carr, et al.Pageof 4